Skip to main content
Top
Published in: Pituitary 1/2015

01-02-2015

Combined high-field intraoperative magnetic resonance imaging and endoscopy increase extent of resection and progression-free survival for pituitary adenomas

Authors: Peter T. Sylvester, John A. Evans, Gregory J. Zipfel, Richard A. Chole, Ravindra Uppaluri, Bruce H. Haughey, Anne E. Getz, Julie Silverstein, Keith M. Rich, Albert H. Kim, Ralph G. Dacey, Michael R. Chicoine

Published in: Pituitary | Issue 1/2015

Login to get access

Abstract

Purpose

The clinical benefit of combined intraoperative magnetic resonance imaging (iMRI) and endoscopy for transsphenoidal pituitary adenoma resection has not been completely characterized. This study assessed the impact of microscopy, endoscopy, and/or iMRI on progression-free survival, extent of resection status (gross-, near-, and sub-total resection), and operative complications.

Methods

Retrospective analyses were performed on 446 transsphenoidal pituitary adenoma surgeries at a single institution between 1998 and 2012. Multivariate analyses were used to control for baseline characteristics, differences during extent of resection status, and progression-free survival analysis.

Results

Additional surgery was performed after iMRI in 56/156 cases (35.9 %), which led to increased extent of resection status in 15/156 cases (9.6 %). Multivariate ordinal logistic regression revealed no increase in extent of resection status following iMRI or endoscopy alone; however, combining these modalities increased extent of resection status (odds ratio 2.05, 95 % CI 1.21–3.46) compared to conventional transsphenoidal microsurgery. Multivariate Cox regression revealed that reduced extent of resection status shortened progression-free survival for near- versus gross-total resection [hazard ratio (HR) 2.87, 95 % CI 1.24–6.65] and sub- versus near-total resection (HR 2.10; 95 % CI 1.00–4.40). Complication comparisons between microscopy, endoscopy, and iMRI revealed increased perioperative deaths for endoscopy versus microscopy (4/209 and 0/237, respectively), but this difference was non-significant considering multiple post hoc comparisons (Fisher exact, p = 0.24).

Conclusions

Combined use of endoscopy and iMRI increased pituitary adenoma extent of resection status compared to conventional transsphenoidal microsurgery, and increased extent of resection status was associated with longer progression-free survival. Treatment modality combination did not significantly impact complication rate.
Literature
1.
go back to reference Chang EF, Zada G, Kim S et al (2008) Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas. J Neurosurg 108:736–745PubMedCrossRef Chang EF, Zada G, Kim S et al (2008) Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas. J Neurosurg 108:736–745PubMedCrossRef
2.
go back to reference Goudakos JK, Markou KD, Georgalas C (2011) Endoscopic versus microscopic trans-sphenoidal pituitary surgery: a systematic review and meta-analysis. Clin Otolaryngol 36:212–220PubMedCrossRef Goudakos JK, Markou KD, Georgalas C (2011) Endoscopic versus microscopic trans-sphenoidal pituitary surgery: a systematic review and meta-analysis. Clin Otolaryngol 36:212–220PubMedCrossRef
3.
go back to reference Tabaee A, Anand VK, Barrón Y et al (2009) Endoscopic pituitary surgery: a systematic review and meta-analysis. J Neurosurg 111:545–554PubMedCrossRef Tabaee A, Anand VK, Barrón Y et al (2009) Endoscopic pituitary surgery: a systematic review and meta-analysis. J Neurosurg 111:545–554PubMedCrossRef
4.
go back to reference Cho D-Y, Liau W-R (2002) Comparison of endonasal endoscopic surgery and sublabial microsurgery for prolactinomas. Surg Neurol 58:371–375PubMedCrossRef Cho D-Y, Liau W-R (2002) Comparison of endonasal endoscopic surgery and sublabial microsurgery for prolactinomas. Surg Neurol 58:371–375PubMedCrossRef
5.
go back to reference Chole RA, Lim C, Dunham B et al (2011) A novel transnasal transsphenoidal speculum: a design for both microscopic and endoscopic transsphenoidal pituitary surgery. J Neurosurg 114:1380–1385PubMed Chole RA, Lim C, Dunham B et al (2011) A novel transnasal transsphenoidal speculum: a design for both microscopic and endoscopic transsphenoidal pituitary surgery. J Neurosurg 114:1380–1385PubMed
6.
go back to reference D’Haens J, Van Rompaey K, Stadnik T et al (2009) Fully endoscopic transsphenoidal surgery for functioning pituitary adenomas: a retrospective comparison with traditional transsphenoidal microsurgery in the same institution. Surg Neurol 72:336–340PubMedCrossRef D’Haens J, Van Rompaey K, Stadnik T et al (2009) Fully endoscopic transsphenoidal surgery for functioning pituitary adenomas: a retrospective comparison with traditional transsphenoidal microsurgery in the same institution. Surg Neurol 72:336–340PubMedCrossRef
7.
go back to reference McLaughlin N, Eisenberg AA, Cohan P et al (2013) Value of endoscopy for maximizing tumor removal in endonasal transsphenoidal pituitary adenoma surgery. J Neurosurg 118:613–620PubMedCrossRef McLaughlin N, Eisenberg AA, Cohan P et al (2013) Value of endoscopy for maximizing tumor removal in endonasal transsphenoidal pituitary adenoma surgery. J Neurosurg 118:613–620PubMedCrossRef
8.
go back to reference Messerer M, De Battista JC, Raverot G et al (2011) Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal. Neurosurg Focus 30:E11PubMedCrossRef Messerer M, De Battista JC, Raverot G et al (2011) Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal. Neurosurg Focus 30:E11PubMedCrossRef
9.
go back to reference Ammirati M, Wei L, Ciric I (2013) Short-term outcome of endoscopic versus microscopic pituitary adenoma surgery: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 84:843–849PubMedCentralPubMedCrossRef Ammirati M, Wei L, Ciric I (2013) Short-term outcome of endoscopic versus microscopic pituitary adenoma surgery: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 84:843–849PubMedCentralPubMedCrossRef
10.
go back to reference Starke RM, Raper DMS, Payne SC et al (2013) Endoscopic versus microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission. J Clin Endocrinol Metab 98:1–10CrossRef Starke RM, Raper DMS, Payne SC et al (2013) Endoscopic versus microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission. J Clin Endocrinol Metab 98:1–10CrossRef
11.
go back to reference Anand VK, Schwartz TH, Hiltzik DH, Kacker A (2006) Endoscopic transsphenoidal pituitary surgery with real-time intraoperative magnetic resonance imaging. Am J Rhinol 20:401–405PubMedCrossRef Anand VK, Schwartz TH, Hiltzik DH, Kacker A (2006) Endoscopic transsphenoidal pituitary surgery with real-time intraoperative magnetic resonance imaging. Am J Rhinol 20:401–405PubMedCrossRef
12.
go back to reference Berkmann S, Fandino J, Zosso S et al (2011) Intraoperative magnetic resonance imaging and early prognosis for vision after transsphenoidal surgery for sellar lesions. J Neurosurg 115:518–527PubMedCrossRef Berkmann S, Fandino J, Zosso S et al (2011) Intraoperative magnetic resonance imaging and early prognosis for vision after transsphenoidal surgery for sellar lesions. J Neurosurg 115:518–527PubMedCrossRef
13.
go back to reference Fahlbusch R, Ganslandt O, Buchfelder M et al (2001) Intraoperative magnetic resonance imaging during transsphenoidal surgery. J Neurosurg 95:381–390PubMedCrossRef Fahlbusch R, Ganslandt O, Buchfelder M et al (2001) Intraoperative magnetic resonance imaging during transsphenoidal surgery. J Neurosurg 95:381–390PubMedCrossRef
14.
go back to reference Gerlach R, du Mesnil de Rochemont R, Gasser T et al (2008) Feasibility of Polestar N20, an ultra-low-field intraoperative magnetic resonance imaging system in resection control of pituitary macroadenomas: lessons learned from the first 40 cases. Neurosurgery 63:272–275PubMedCrossRef Gerlach R, du Mesnil de Rochemont R, Gasser T et al (2008) Feasibility of Polestar N20, an ultra-low-field intraoperative magnetic resonance imaging system in resection control of pituitary macroadenomas: lessons learned from the first 40 cases. Neurosurgery 63:272–275PubMedCrossRef
15.
go back to reference Schwartz TH, Stieg PE, Anand VK (2006) Endoscopic transsphenoidal pituitary surgery with intraoperative magnetic resonance imaging. Neurosurgery 58:44–51CrossRef Schwartz TH, Stieg PE, Anand VK (2006) Endoscopic transsphenoidal pituitary surgery with intraoperative magnetic resonance imaging. Neurosurgery 58:44–51CrossRef
16.
go back to reference Vitaz TW, Inkabi KE, Carrubba CJ (2011) Intraoperative MRI for transsphenoidal procedures: short-term outcome for 100 consecutive cases. Clin Neurol Neurosurg 113:731–735PubMedCrossRef Vitaz TW, Inkabi KE, Carrubba CJ (2011) Intraoperative MRI for transsphenoidal procedures: short-term outcome for 100 consecutive cases. Clin Neurol Neurosurg 113:731–735PubMedCrossRef
17.
go back to reference Wu JS, Shou XF, Yao CJ et al (2009) Transsphenoidal pituitary macroadenomas resection guided by PoleStar N20 low-field intraoperative magnetic resonance imaging: comparison with early postoperative high-field magnetic resonance imaging. Neurosurgery 65:61–63 Wu JS, Shou XF, Yao CJ et al (2009) Transsphenoidal pituitary macroadenomas resection guided by PoleStar N20 low-field intraoperative magnetic resonance imaging: comparison with early postoperative high-field magnetic resonance imaging. Neurosurgery 65:61–63
18.
go back to reference Fahlbusch R, Keller B, Ganslandt O et al (2005) Transsphenoidal surgery in acromegaly investigated by intraoperative high-field magnetic resonance imaging. Eur J Endocrinol 153:239–248PubMedCrossRef Fahlbusch R, Keller B, Ganslandt O et al (2005) Transsphenoidal surgery in acromegaly investigated by intraoperative high-field magnetic resonance imaging. Eur J Endocrinol 153:239–248PubMedCrossRef
19.
go back to reference Netuka D, Masopust V, Belsan T et al (2011) One year experience with 3.0 T intraoperative MRI in pituitary surgery. Acta Neurochir Suppl 109:3–5CrossRef Netuka D, Masopust V, Belsan T et al (2011) One year experience with 3.0 T intraoperative MRI in pituitary surgery. Acta Neurochir Suppl 109:3–5CrossRef
20.
go back to reference Nimsky C, Ganslandt O, Fahlbusch R (2005) Comparing 0.2 tesla with 1.5 tesla intraoperative magnetic resonance imaging analysis of setup, workflow, and efficiency. Acad Radiol 12:1065–1079PubMedCrossRef Nimsky C, Ganslandt O, Fahlbusch R (2005) Comparing 0.2 tesla with 1.5 tesla intraoperative magnetic resonance imaging analysis of setup, workflow, and efficiency. Acad Radiol 12:1065–1079PubMedCrossRef
21.
go back to reference Nimsky C, Ganslandt O, Von Keller B et al (2004) Intraoperative high-field-strength MR imaging: implementation and experience in 200 patients. Radiology 233:67–78PubMedCrossRef Nimsky C, Ganslandt O, Von Keller B et al (2004) Intraoperative high-field-strength MR imaging: implementation and experience in 200 patients. Radiology 233:67–78PubMedCrossRef
22.
go back to reference Nimsky C, Keller B, Ganslandt O et al (2006) Intraoperative high-field magnetic resonance imaging in transsphenoidal surgery of hormonally inactive pituitary macroadenomas. Neurosurgery 58:105–114CrossRef Nimsky C, Keller B, Ganslandt O et al (2006) Intraoperative high-field magnetic resonance imaging in transsphenoidal surgery of hormonally inactive pituitary macroadenomas. Neurosurgery 58:105–114CrossRef
23.
go back to reference Pamir MN, Peker S, Ozek MM, Dincer A (2006) Intraoperative MR imaging: preliminary results with 3 tesla MR system. Acta Neurochir Suppl 98:97–100PubMedCrossRef Pamir MN, Peker S, Ozek MM, Dincer A (2006) Intraoperative MR imaging: preliminary results with 3 tesla MR system. Acta Neurochir Suppl 98:97–100PubMedCrossRef
24.
go back to reference Szerlip NJ, Zhang Y-CC, Placantonakis DG et al (2011) Transsphenoidal resection of sellar tumors using high-field intraoperative magnetic resonance imaging. Skull Base 21:223–232PubMedCentralPubMedCrossRef Szerlip NJ, Zhang Y-CC, Placantonakis DG et al (2011) Transsphenoidal resection of sellar tumors using high-field intraoperative magnetic resonance imaging. Skull Base 21:223–232PubMedCentralPubMedCrossRef
25.
go back to reference Coburger J, Konig R, Seitz K, et al (2014) Determining the utility of intraoperative magnetic resonance imaging for transsphenoidal surgery: a retrospective study. J Neurosurg 120:346–356 Coburger J, Konig R, Seitz K, et al (2014) Determining the utility of intraoperative magnetic resonance imaging for transsphenoidal surgery: a retrospective study. J Neurosurg 120:346–356
26.
go back to reference Chicoine MR, Lim CC, Evans JA et al (2011) Implementation and preliminary clinical experience with the use of ceiling mounted mobile high field intraoperative magnetic resonance imaging between two operating rooms. Acta Neurochir Suppl 109:97–102PubMedCrossRef Chicoine MR, Lim CC, Evans JA et al (2011) Implementation and preliminary clinical experience with the use of ceiling mounted mobile high field intraoperative magnetic resonance imaging between two operating rooms. Acta Neurochir Suppl 109:97–102PubMedCrossRef
27.
go back to reference Hall WA, Kowalik K, Liu H et al (2003) Costs and benefits of intraoperative MR-guided brain tumor resection. Acta Neurochir Suppl 85:137–142PubMedCrossRef Hall WA, Kowalik K, Liu H et al (2003) Costs and benefits of intraoperative MR-guided brain tumor resection. Acta Neurochir Suppl 85:137–142PubMedCrossRef
28.
go back to reference Theodosopoulos PV, Leach J, Kerr RG et al (2010) Maximizing the extent of tumor resection during transsphenoidal surgery for pituitary macroadenomas: can endoscopy replace intraoperative magnetic resonance imaging? J Neurosurg 112:736–743PubMedCrossRef Theodosopoulos PV, Leach J, Kerr RG et al (2010) Maximizing the extent of tumor resection during transsphenoidal surgery for pituitary macroadenomas: can endoscopy replace intraoperative magnetic resonance imaging? J Neurosurg 112:736–743PubMedCrossRef
29.
go back to reference Chicoine RM, Evans AJ, Wippold JF et al (2011) Comparison of intraoperative and postoperative MRI for endoscopic transsphenoidal resection of pituitary macroadenomas. Skull Base 21:A064CrossRef Chicoine RM, Evans AJ, Wippold JF et al (2011) Comparison of intraoperative and postoperative MRI for endoscopic transsphenoidal resection of pituitary macroadenomas. Skull Base 21:A064CrossRef
30.
go back to reference Haydon DH, Chicoine MR, Dacey RG (2013) The impact of high-field-strength intraoperative magnetic resonance imaging on brain tumor management. Neurosurgery 60:92–97PubMedCrossRef Haydon DH, Chicoine MR, Dacey RG (2013) The impact of high-field-strength intraoperative magnetic resonance imaging on brain tumor management. Neurosurgery 60:92–97PubMedCrossRef
31.
go back to reference Leuthardt EC, Lim CCH, Shah MN et al (2011) Use of movable high-field-strength intraoperative magnetic resonance imaging with awake craniotomies for resection of gliomas: preliminary experience. Neurosurgery 69:194–205PubMedCrossRef Leuthardt EC, Lim CCH, Shah MN et al (2011) Use of movable high-field-strength intraoperative magnetic resonance imaging with awake craniotomies for resection of gliomas: preliminary experience. Neurosurgery 69:194–205PubMedCrossRef
32.
go back to reference Shah MN, Leonard JR, Inder G et al (2012) Intraoperative magnetic resonance imaging to reduce the rate of early reoperation for lesion resection in pediatric neurosurgery. J Neurosurg Pediatr 9:259–264PubMedCrossRef Shah MN, Leonard JR, Inder G et al (2012) Intraoperative magnetic resonance imaging to reduce the rate of early reoperation for lesion resection in pediatric neurosurgery. J Neurosurg Pediatr 9:259–264PubMedCrossRef
33.
go back to reference De Paiva Neto MA, Vandergrift A, Fatemi N et al (2010) Endonasal transsphenoidal surgery and multimodality treatment for giant pituitary adenomas. Clin Endocrinol 72:512–519CrossRef De Paiva Neto MA, Vandergrift A, Fatemi N et al (2010) Endonasal transsphenoidal surgery and multimodality treatment for giant pituitary adenomas. Clin Endocrinol 72:512–519CrossRef
34.
go back to reference Di Maio S, Cavallo LM, Esposito F et al (2011) Extended endoscopic endonasal approach for selected pituitary adenomas: early experience. J Neurosurg 114:345–353PubMedCrossRef Di Maio S, Cavallo LM, Esposito F et al (2011) Extended endoscopic endonasal approach for selected pituitary adenomas: early experience. J Neurosurg 114:345–353PubMedCrossRef
35.
go back to reference Arnaldi G, Angeli A, Atkinson A et al (2003) Diagnosis and complications of Cushing’s Syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593–5602PubMedCrossRef Arnaldi G, Angeli A, Atkinson A et al (2003) Diagnosis and complications of Cushing’s Syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593–5602PubMedCrossRef
36.
go back to reference Casanueva FF, Molitch ME, Schlechte JA et al (2006) Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol 65:265–273CrossRef Casanueva FF, Molitch ME, Schlechte JA et al (2006) Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol 65:265–273CrossRef
37.
go back to reference Giustina A, Chanson P, Bronstein MD et al (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95:3141–3148PubMedCrossRef Giustina A, Chanson P, Bronstein MD et al (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95:3141–3148PubMedCrossRef
38.
go back to reference Ekramullah SM, Saitoh Y, Arita N et al (1996) The correlation of Ki-67 staining indices with tumour doubling times in regrowing non-functioning pituitary adenomas. Acta Neurochir 138:1449–1455PubMedCrossRef Ekramullah SM, Saitoh Y, Arita N et al (1996) The correlation of Ki-67 staining indices with tumour doubling times in regrowing non-functioning pituitary adenomas. Acta Neurochir 138:1449–1455PubMedCrossRef
39.
go back to reference Green VL, Atkin SL, Speirs V et al (1996) Cytokine expression in human anterior pituitary adenomas. Clin Endocrinol 45:179–185CrossRef Green VL, Atkin SL, Speirs V et al (1996) Cytokine expression in human anterior pituitary adenomas. Clin Endocrinol 45:179–185CrossRef
40.
go back to reference Tanaka Y, Hongo K, Tada T et al (2003) Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index. J Neurosurg 98:359–365PubMedCrossRef Tanaka Y, Hongo K, Tada T et al (2003) Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index. J Neurosurg 98:359–365PubMedCrossRef
41.
go back to reference Buchfelder M, Schlaffer S-M (2012) Intraoperative magnetic resonance imaging during surgery for pituitary adenomas: pros and cons. Endocrine 42:483–495PubMedCrossRef Buchfelder M, Schlaffer S-M (2012) Intraoperative magnetic resonance imaging during surgery for pituitary adenomas: pros and cons. Endocrine 42:483–495PubMedCrossRef
42.
go back to reference Lang MJ, Kelly JJ, Sutherland GR (2011) A moveable 3-Tesla intraoperative magnetic resonance imaging system. Neurosurgery 68:168–179PubMedCrossRef Lang MJ, Kelly JJ, Sutherland GR (2011) A moveable 3-Tesla intraoperative magnetic resonance imaging system. Neurosurgery 68:168–179PubMedCrossRef
43.
go back to reference Koutourousiou M, Gardner PA, Fernandez-Miranda JC et al (2013) Endoscopic endonasal surgery for giant pituitary adenomas: advantages and limitations. J Neurosurg 118:621–631PubMedCrossRef Koutourousiou M, Gardner PA, Fernandez-Miranda JC et al (2013) Endoscopic endonasal surgery for giant pituitary adenomas: advantages and limitations. J Neurosurg 118:621–631PubMedCrossRef
44.
go back to reference Losa M, Mortini P, Barzaghi R et al (2008) Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence. J Neurosurg 108:525–532PubMedCrossRef Losa M, Mortini P, Barzaghi R et al (2008) Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence. J Neurosurg 108:525–532PubMedCrossRef
45.
go back to reference Berker M, Hazer DB, Yücel T et al (2012) Complications of endoscopic surgery of the pituitary adenomas: analysis of 570 patients and review of the literature. Pituitary 15:288–300PubMedCrossRef Berker M, Hazer DB, Yücel T et al (2012) Complications of endoscopic surgery of the pituitary adenomas: analysis of 570 patients and review of the literature. Pituitary 15:288–300PubMedCrossRef
46.
go back to reference Mortini P, Losa M, Barzaghi R et al (2005) Results of transsphenoidal surgery in a large series of patients with pituitary adenoma. Neurosurgery 56:1222–1233PubMedCrossRef Mortini P, Losa M, Barzaghi R et al (2005) Results of transsphenoidal surgery in a large series of patients with pituitary adenoma. Neurosurgery 56:1222–1233PubMedCrossRef
47.
go back to reference Frank G, Pasquini E, Farneti G et al (2006) The endoscopic versus the traditional approach in pituitary surgery. Neuroendocrinology 83:240–248PubMedCrossRef Frank G, Pasquini E, Farneti G et al (2006) The endoscopic versus the traditional approach in pituitary surgery. Neuroendocrinology 83:240–248PubMedCrossRef
48.
go back to reference Kabil MS, Eby JB, Shahinian HK (2005) Fully endoscopic endonasal vs. transseptal transsphenoidal pituitary surgery. Minim Invasive Neurosurg 48:348–354PubMedCrossRef Kabil MS, Eby JB, Shahinian HK (2005) Fully endoscopic endonasal vs. transseptal transsphenoidal pituitary surgery. Minim Invasive Neurosurg 48:348–354PubMedCrossRef
49.
go back to reference Halvorsen H, Ramm-Pettersen J, Josefsen R, et al. (2013) Surgical complications after transsphenoidal microscopic and endoscopic surgery for pituitary adenoma: a consecutive series of 506 procedures. Acta Neurochir (Wien) Epub before print Halvorsen H, Ramm-Pettersen J, Josefsen R, et al. (2013) Surgical complications after transsphenoidal microscopic and endoscopic surgery for pituitary adenoma: a consecutive series of 506 procedures. Acta Neurochir (Wien) Epub before print
50.
go back to reference Jane JJ, Laws E (2001) The surgical management of pituitary adenomas in a series of 3,093 patients. J Am Coll Surg 193:651–659PubMedCrossRef Jane JJ, Laws E (2001) The surgical management of pituitary adenomas in a series of 3,093 patients. J Am Coll Surg 193:651–659PubMedCrossRef
51.
go back to reference DeKlotz TR, Chia SH, Lu W et al (2012) Meta-analysis of endoscopic versus sublabial pituitary surgery. Laryngoscope 122:511–518PubMedCrossRef DeKlotz TR, Chia SH, Lu W et al (2012) Meta-analysis of endoscopic versus sublabial pituitary surgery. Laryngoscope 122:511–518PubMedCrossRef
52.
go back to reference Ciric I, Ragin A, Baumgartner C, Pierce D (1997) Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery 40:225–236PubMedCrossRef Ciric I, Ragin A, Baumgartner C, Pierce D (1997) Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery 40:225–236PubMedCrossRef
53.
go back to reference Senft C, Bink A, Franz K et al (2011) Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol 12:997–1003PubMedCrossRef Senft C, Bink A, Franz K et al (2011) Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol 12:997–1003PubMedCrossRef
54.
go back to reference Stummer W (2008) Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62:564–576PubMedCrossRef Stummer W (2008) Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62:564–576PubMedCrossRef
Metadata
Title
Combined high-field intraoperative magnetic resonance imaging and endoscopy increase extent of resection and progression-free survival for pituitary adenomas
Authors
Peter T. Sylvester
John A. Evans
Gregory J. Zipfel
Richard A. Chole
Ravindra Uppaluri
Bruce H. Haughey
Anne E. Getz
Julie Silverstein
Keith M. Rich
Albert H. Kim
Ralph G. Dacey
Michael R. Chicoine
Publication date
01-02-2015
Publisher
Springer US
Published in
Pituitary / Issue 1/2015
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-014-0560-2

Other articles of this Issue 1/2015

Pituitary 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.